BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  AstraZeneca Looks to Challenge GSK in SLE Following Phase III Success

  The TULIP 2 trial was the second Phase III trial that assessed the safety and efficacy of anifrolumab as a treatment for adults with moderate-to-severe SLE.

  August 29, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Is a CDK7 Inhibitor the Answer to Killing Prostate Cancer?

  Researchers may have found a new manner of treating a deadly form of prostate cancer by blocking a specific protein.

  August 29, 2019

   · 

  2 min read

   · 

  Alex Keown
• Deals

  Taiho Pharmaceutical Invests in New Venture Capital Fund - Aug. 29, 2019

  Taiho Pharmaceutical Co., Ltd. announced on August 29 that the company has entered into an agreement to invest up to US$30 million in Remiges Biopharma Fund II, LP a biopharma venture capital fund formed by Remiges Ventures, Inc.

  August 29, 2019

   · 

  2 min read
• Business

  Verdemed, which is building the medical cannabis brand of choice for Latin America, announces the appointment of Mr. David Beatty as a member of its Board of Directors, and Mr. Alexandre Penha as Chief Financial Officer

  VERDEMED HOLDINGS INC. is pleased to announce the appointment of Mr. David Beatty as a member of its Board of Directors, and Mr. Alexandre Penha as Chief Financial Officer.

  August 29, 2019

   · 

  5 min read
• East Asia Marine Expo 2019 to Be Held in Qingdao on September 4

  The 2019 East Asia Marine Expo is to be held from September 4th to 8th, 2019 at the Qingdao Cosmopolitan Exposition.

  August 29, 2019

   · 

  1 min read
• Business

  IRRAS Publishes Interim Report for the Period January to June 2019

  During the second quarter, we reached a significant milestone by recording our first IRRAflow revenue in the United States.

  August 29, 2019

   · 

  4 min read
• Nordic Nanovector ASA: Invitation to R&D Day in Oslo and Webcast

  Nordic Nanovector ASA announces that it will host a R&D Day in Oslo on Tuesday, 17 September 2019 from 9:30am to 12:30pm CEST.

  August 29, 2019

   · 

  4 min read
• Media Advisory - Canadian Cancer Society Releases Canadian Cancer Statistics 2019 on Wednesday, September 4

  Canadian Cancer Statistics 2019 will be released by the Canadian Cancer Society.

  August 29, 2019

   · 

  1 min read
• Deals

  Q2 Report 2019 - Invitation to Conference Call and Audiocast

  CET IRRAS will host a conference call and an online presentation of its Q2 2019 interim report.

  August 29, 2019

   · 

  1 min read
• Business

  Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

  Luye Pharma Group released its financial results for the first half of 2019 on August 28.

  August 29, 2019

   · 

  6 min read